Association between oral bisphosphonate exposure and esophageal or gastric cancer.

<p>Association between oral bisphosphonate exposure and esophageal or gastric cancer.</p

Concerns about clinical application of pharmacogenomic testing.

<p>Respondents were asked to select their two biggest concerns from a list. *Skeptics include those who were neutral, disagreed, or strongly disagreed with the idea of incorporating the integrated pharmacogenomics test into the National Health Insurance health examination.</p

Patient demographics and clinical information for cases and controls.

<p>Patient demographics and clinical information for cases and controls.</p

Association between oral bisphosphonate exposure and esophageal or gastric cancer according to CDE.

<p>Association between oral bisphosphonate exposure and esophageal or gastric cancer according to CDE.</p

Multinomial multivariate logistic regression analysis results for factors that are associated with public awareness of personalized medicine in Korea.

<p>Multinomial multivariate logistic regression analysis results for factors that are associated with public awareness of personalized medicine in Korea.</p

Awareness and attitudes of the general public toward personalized medicine using pharmacogenomic information.

<p>Awareness and attitudes of the general public toward personalized medicine using pharmacogenomic information.</p

Flow of case and control selection.

<p>Flow of case and control selection.</p

Multivariate logistic regression analysis results for factors that are associated with public concerns about clinical application of pharmacogenomic testing in Korea.

<p>Multivariate logistic regression analysis results for factors that are associated with public concerns about clinical application of pharmacogenomic testing in Korea.</p

Socio-demographic and health characteristics of the survey respondents.

<p>Socio-demographic and health characteristics of the survey respondents.</p